dihexa australia (PNB-0408) | c-Met/HGFR Activator Dihexa | c-Met Chemical |
Description
Hepatocyte growth factor gene therapy of liver cirrhosis in rats
NM and RA wrote the manuscript
Amount in the Published Research Literature The following administration ranges describe the protocols used in the peer-reviewed rodent literature on Dihexa
Weight loss on peptide therapy is not linear, and temporary stalls of 1-3 weeks are normal even on optimal protocols
